Selegine in the treatment of Alzheimers disease: a long-term randomized placebo-controlled trial

FILIP, Václav, Eduard KOLIBÁŠ, Jaromír ŠVESTKA, Radek RYŠÁNEK and Eva ČEŠKOVÁ. Selegine in the treatment of Alzheimers disease: a long-term randomized placebo-controlled trial (Selegine in the treatment of Alzheimers disease: a long-term randomized placebo-controlled). Journal of Psychiatry&Neuroscience. Kanada: Canadian Medical Association, 1999, vol. 24, No 3, p. 234-243.

Basic information

Original name

Selegine in the treatment of Alzheimers disease: a long-term randomized placebo-controlled trial

Name in Czech

Léčba u Alzheimerovy choroby:longitudiální randomizovaná placebo-kontrolní pokus

Authors

FILIP, Václav (203 Czech Republic), Eduard KOLIBÁŠ (203 Czech Republic), Jaromír ŠVESTKA (203 Czech Republic, guarantor), Radek RYŠÁNEK (203 Czech Republic) and Eva ČEŠKOVÁ (203 Czech Republic)

Edition

Journal of Psychiatry&Neuroscience, Kanada, Canadian Medical Association, 1999

---

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30000 3. Medical and Health Sciences

Country of publisher

Canada

Confidentiality degree

není předmětem státního či obchodního tajemství

Organization unit

Faculty of Medicine

Keywords in English

aged; Alzheimer disease; cognition; dementia; monoamineoxidase; inhibitors;nootropic

Tags

aged, Alzheimer disease, cognition, dementia, inhibitors, monoamineoxidase, nootropic

---

Abstract

V originále

Selegine in the treatment of Alzheimers disease: a long-term randomized placebo-controlled trial

In Czech

Léčba pacientů s Alzheimerovou chorobou - rozsah, druh, účinnost - je cílem kontrolní studie.